Survey of small antifungal peptides with chemotherapeutic potential

Current Pharmaceutical Biotechnology

Volumn 12, Issue 8, 2011, Pages 1263-1291

  Desbois, Andrew P ^a   Tschörner, David ^a   Coote, Peter J ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Antimicrobial peptides; Candida albicans; Drug resistance; Lactoferrin; Mechanism of action; Yeast

Indexed keywords

ANDROCTONIN; ANTIFUNGAL AGENT; ASCAPHIN 8; AUREIN 1.2; BUFORIN II; CATHELICIDIN BF 15; CITROPIN 1.1; CRYPTONIN; DECORALIN; DERMASEPTIN S3; GAEGURIN 5; GAEGURIN 6; HEPCIDIN 25; INTERMEDIN; LATARCIN 3A; MAGAININ 2; MASTOPARAN VB1; MISGURIN; NIGROCIN OG21; PENETRATIN; PEXIGANAN; PISCIDIN P3; POLYPEPTIDE ANTIBIOTIC AGENT; PONERICIN G6; RANALEXIN; SPINIGERIN; TEMPORIN A; TIGERININ 1; UNCLASSIFIED DRUG; UNINDEXED DRUG; VESPID CHEMOTACTIC PEPTIDE 5G;

AMINO ACID SEQUENCE; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BIOAVAILABILITY; COST; CYTOTOXICITY; DRUG CYTOTOXICITY; DRUG POTENCY; ERYTHROCYTE; HUMAN; IC 50; IMMUNOGENICITY; IN VIVO STUDY; MAMMAL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANT FUNGUS INTERACTION; PROTEIN ANALYSIS; PROTEIN PROCESSING; PROTEIN STRUCTURE;

ANTIFUNGAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; DRUG RESISTANCE, FUNGAL; FUNGI;

ANIMALIA; CANDIDA ALBICANS; FUNGI; MAMMALIA;

EID: 79959956955     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111796117265     Document Type: Article

References (226)

1. Pfaller, M. A.; Diekema, D.J. Epidemiology of invasive Candidiasis: a persistent public health problem. Clin. Microbiol. Rev., 2007, 20, 133-163.
2. Andres, E.; Dimarcq, J.L. Cationic antimicrobial peptides: from innate immunity study to drug development. Up date. Med. Maladies Infec., 2007, 37, 194-199.
3. Chan, D.I.; Prenner, E.J.; Vogel, H.J. Tryptophan- and argininerich antimicrobial peptides: structures and mechanisms of action. Biochim. Biophys. Acta, 2006, 1758, 1184-1202.
4. De Lucca, A.J.; Walsh, T.J. Antifungal peptides: novel therapeutic compounds against emerging pathogens. Antimicrob. Agents Chemother., 1999, 43, 1-11.
5. Wang, Z.; Wang, G. APD: the antimicrobial peptide database. Nucl. Acids Res., 2004, 32, D590-D592.
6. Wang, G.; Li, X.; Wang, Z. APD2: the updated antimicrobial peptide database and its application in peptide design. Nucl. Acids Res., 2009, 37, D933-D937.
7. Thomas, S.; Karnik, S.; Barai, R.S.; Jayaraman, V.K.; Idicula- Thomas, S. CAMP: a useful resource for research on antimicrobial peptides. Nucl. Acids Res., 2010, 38, D774-D780.
8. Fernandes, J.M.; Kemp, G.D.; Molle, M.G.; Smith, V.J. Antimicrobial properties of histone H2A from skin secretions of rainbow trout, Oncorhynchus mykiss. Biochem. J., 2002, 368, 611-620.
9. Fontana, R.; Mendes, M.A.; De Souza, B.M.; Konno, K.; Cesar, L.M.; Malaspina, O.; Palma, M.S. Jelleines: a family of antimicrobial peptides from the Royal Jelly of honeybees (Apis mellifera). Peptides, 2004, 25, 919-928.
10. Lupetti, A.; Brouwer, C.P.J.M.; Bogaards, S.J.P.; Welling, M.M.; De Heer, E.; Campa, M.; Van Dissel, J.T.; Friesen, R.H.E.; Nibbering, P.H. Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infection. J. Infect. Dis., 2007, 196, 1416-1423.
11. Rubinchik, E.; Dugourd, D.; Algara, T.; Pasetka, C.; Friedland, H.D. Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models. Int. J. Antimicrob. Agents, 2009, 34, 457-461.
12. Werle, M.; Bernkop-Schnürch, A. Strategies to improve plasma half life time of peptide and protein drugs. Amino Acids, 2006, 30, 351-367.
13. Ajesh, K.; Sreejith, K. Peptide antibiotics: an alternative and effective antimicrobial strategy to circumvent fungal infections. Peptides, 2009, 30, 999-1006.
14. Nguyen, T.H.; Fleet, G.H.; Rogers, P.L. Composition of the cell walls of several yeast species. Appl. Microbiol. Biotechnol., 1998, 50, 206-212.
15. Dielbandhoesing, S.K.; Zhang, H.; Caro, L.H.P.; van der Vaart, J.M.; Klis, F.M.; Verrips, C.T.; Brul, S. Specific cell wall proteins confer resistance to nisin upon yeast cells. Appl. Environ. Microbiol., 1998, 64, 4047-4052.
16. Harris, M.; Mora-Montes, H.M.; Gow, N.A.; Coote, P.J. Loss of mannosylphosphate from Candida albicans cell wall proteins results in enhanced resistance to the inhibitory effect of a cationic antimicrobial peptide via reduced peptide binding to the cell surface. Microbiology, 2009, 155, 1058-1070.
17. Yeaman, M.R.; Yount, N.Y. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev., 2003, 55, 27-55.
18. Smith, V.J.; Desbois, A.P.; Dyrynda, E.A. Conventional and unconventional antimicrobials from fish, marine invertebrates and micro-algae. Mar. Drugs, 2010, 8, 1213-1262.
19. Sperstad, S.V.; Haug, T.; Vasskog, T.; Stensvag, K. Hyastatin, a glycine-rich multi-domain antimicrobial peptide isolated from the spider crab (Hyas araneus) hemocytes. Mol. Immunol., 2009, 46, 2604-2612.
20. Blondelle, S.E.; Lohner, K.; Aguilar, M. Lipid-induced conformation and lipid-binding properties of cytolytic and antimicrobial peptides: determination and biological specificity. Biochim. Biophys. Acta, 1999, 1462, 89-108.
21. Shai, Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta, 1999, 1462, 55-70.
22. Rozek, T.; Wegener, K.L.; Bowie, J.H.; Olver, I.N.; Carver, J.A.; Wallace, J.C.; Tyler, M.J. The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2. Eur. J. Biochem., 2000, 267, 5330-5341.
23. Gehman, J.D.; Luc, F.; Hall, K.; Lee, T.H.; Boland, M.P.; Pukala, T.L.; Bowie, J.H.; Aguilar, M.I.; Separovic, F. Effect of antimicrobial peptides from Australian tree frogs on anionic phospholipid membranes. Biochemistry, 2008, 47, 8557-8565.
24. Ehrenstein, G.; Lecar, H. Electrically gated ionic channels in lipid bilayers. Q. Rev. Biophys., 1977, 10, 1-34.
25. Papo, N.; Shai, Y. Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes? Peptides, 2003, 24, 1693-1703.
26. Shai, Y. Mode of action of membrane active antimicrobial peptides. Biopolymers, 2002, 66, 236-248.
27. Sengupta, D.; Leontiadou, H.; Mark, A.E.; Marrink, S.J. Toroidal pores formed by antimicrobial peptides show significant disorder. Biochim. Biophys. Acta, 2008, 1778, 2308-2317.
28. Leontiadou, H.; Mark, A.E.; Marrink, S.J. Antimicrobial peptides in action. J. Am. Chem. Soc., 2006, 128, 12156-12161.
29. Won, H.S.; Kang, S.J.; Lee, B.J. Action mechanism and structural requirements of the antimicrobial peptides, gaegurins. Biochim. Biophys. Acta, 2009, 1788, 1620-1629.
30. Konno, K.; Rangel, M.; Oliveira, J.S.; Dos Santos Cabrera, M.P.; Fontana, R.; Hirata, I.Y.; Hide, I.; Nakata, Y.; Mori, K.; Kawano, M.; Fuchino, H.; Sekita, S.; Neto, J.R. Decoralin, a novel linear cationic alpha-helical peptide from the venom of the solitary eumenine wasp Oreumenes Decoratus. Peptides, 2007, 28, 2320-2327.
31. Gasteiger, E.; Hoogland, C.; Gattiker, A.; Duvard, S.; Wilkins, M.R.; Appel, R.D.; Bairoch, A. In: The Proteomics Protocols Handbook; Walker, J.M., Ed.; Humana Press: New York, 2005; pp. 571-607.
32. Simmaco, M.; Mignogna, G.; Canofeni, S.; Miele, R.; Mangoni, M.L.; Barra, D. Temporins, antimicrobial peptides from the European red frog Rana temporaria. Eur. J. Biochem., 1996, 242, 788-792.
33. Mangoni, M.L.; Rinaldi, A.C.; Di Giulio, A.; Mignogna, G.; Bozzi, A.; Barra, D.; Simmaco, M. Structure-function relationships of temporins, small antimicrobial peptides from amphibian skin. Eur. J. Biochem., 2000, 267, 1447-1454.
34. Lu, Y.; Li, J.; Yu, H.; Xu, X.; Liang, J.; Tian, Y.; Ma, D.; Lin, G.; Huang, G.; Lai, R. Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis. Peptides, 2006, 27, 3085-3091.
35. Kamysz, W.; Nadolski, P.; Kedzia, A.; Cirioni, O.; Barchiesi, F.; Giacometti, A.; Scalise, G.; Lukasiak, J.; Okroj, M. In vitro activity of synthetic antimicrobial peptides against Candida. Pol. J. Microbiol., 2006, 55, 303-307.
36. Ambroggio, E.E.; Separovic, F.; Bowie, J.H.; Fdelio, G.D.; Bagatolli, L.A. Direct visualization of membrane leakage induced by the antibiotic peptides: maculatin, citropin, and aurein. Biophys. J., 2005, 89, 1874-1881.
37. Xu, X.; Li, J.; Lu, Q.; Yang, H.; Zhang, Y.; Lai, R. Two families of antimicrobial peptides from wasp (Vespa magnifica) venom. Toxicon, 2006, 47, 249-253.
38. Chen, W.; Yang, X.; Yang, X.; Zhai, L.; Lu, Z.; Liu, J.; Yu, H. Antimicrobial peptides from the venoms of Vespa bicolor Fabricius. Peptides, 2008, 29, 1887-1892.
39. Hirai, Y.; Yasuhara, T.; Yoshida, H.; Nakajima, T.; Fujino, M.; Kitada, C. A new mast cell degranulating peptide mastoparan in the venom of Vespula lewisii. Chem. Pharm. Bull., (Tokyo), 1979, 27, 1942-1944.
40. Dos Santos Cabrera, M.P.; De Souza, B.M.; Fontana, R.; Konno, K.; Palma, M.S.; De Azevedo, W.F.; Neto, J.R. Conformation and lytic activity of eumenine mastoparan: a new antimicrobial peptide from wasp venom. J. Pept. Res., 2004, 64, 95-103.
41. Mukai, H.; Kikuchi, M.; Suzuki, Y.; Munekata, E. A mastoparan analog without lytic effects and its stimulatory mechanisms in mast cells. Biochem. Biophys. Res. Commun., 2007, 362, 51-55.
42. Liu, S.; Wang, F.; Tang, L.; Gui, W.; Cao, P.; Liu, X.; Poon, A.W.; Shaw, P.C.; Jiang, T. Crystal structure of mastoparan from Polistes jadwagae at 1.2 A resolution. J. Struct. Biol., 2007, 160, 28-34.
43. Wang, Y.; Hong, J.; Liu, X.; Yang, H.; Liu, R.; Wu, J.; Wang, A.; Lin, D.; Lai, R. Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotic. PLoS One, 2008, 3, e3217.
44. Doyle, J.; Brinkworth, C.S.; Wegener, K.L.; Carver, J.A.; Llewellyn, L.E.; Olver, I.N.; Bowie, J.H.; Wabnitz, P.A.; Tyler, M.J. nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications: The solution structure of a modified citropin 1.1. Eur. J. Biochem., 2003, 270, 1141-1153.
45. Wegener, K.L.; Wabnitz, P.A.; Carver, J.A.; Bowie, J.H.; Chia, B.C.; Wallace, J.C.; Tyler, M.J. Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa: Solution structure of the antibacterial peptide citropin 1.1. Eur. J. Biochem., 1999, 265, 627-637.
46. Mor, A.; Hani, K.; Nicolas, P. The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms. J. Biol. Chem., 1994, 269, 31635-31641.
47. Mor, A.; Nicolas, P. The NH2-terminal alpha-helical domain 1-18 of dermaseptin is responsible for antimicrobial activity. J. Biol. Chem., 1994, 269, 1934-1939.
48. Moll, G.N.; Brul, S.; Konings, W.N.; Driessen, A.J. Comparison of the membrane interaction and permeabilization by the designed peptide Ac-MB21-NH2 and truncated dermaseptin S3. Biochemistry, 2000, 39, 11907-11912.
49. Coote, P.J.; Holyoak, C.D.; Bracey, D.; Ferdinando, D.P.; Pearce, J.A. Inhibitory action of a truncated derivative of the amphibian skin peptide Dermaseptin s3 on Saccharomyces cerevisiae. Antimicrob. Agents Chemother., 1998, 42, 2160-2170.
50. Morton, C.O.; Dos Santos, S.C.; Coote, P. An amphibian-derived, cationic, alpha-helical antimicrobial peptide kills yeast by caspaseindependent but AIF-dependent programmed cell death. Mol. Microbiol., 2007, 65, 494-507.
51. Morton, C.O.; Hayes, A.; Wilson, M.; Rash, B.M.; Oliver, S.G.; Coote, P. Global phenotype screening and transcript analysis outlines the inhibitory mode(s) of action of two amphibian-derived, α- helical, cationic peptides on Saccharomyces cerevisiae. Antimicrob. Agents Chemother., 2007, 51, 3948-3959.
52. Masman, M.F.; Rodriguez, A.M.; Raimondi, M.; Zacchino, S.A.; Luiten, P.G.; Somlai, C.; Kortvelyesi, T.; Penke, B.; Enriz, R.D. Penetratin and derivatives acting as antifungal agents. Eur. J. Med. Chem., 2009, 44, 212-228.
53. Zhu, W.L.; Shin, S.Y. Antimicrobial and cytolytic activities and plausible mode of bactericidal action of the cell penetrating peptide penetratin and its Lys-linked two-stranded peptide. Chem. Biol. Drug Des., 2009, 73, 209-215.
54. Minn, I.; Kim, H.S.; Kim, S.C. Antimicrobial peptides derived from pepsinogens in the stomach of the bullfrog, Rana catesbeiana. Biochim. Biophys. Acta, 1998, 140, 31-39.
55. Ali, M.F.; Soto, A.; Knoop, F.C.; Conlon, J.M. Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae). Biochim. Biophys. Acta, 2001, 1550, 81-89.
56. Conlon, J.M.; Galadari, S.; Raza, H.; Condamine, E. Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Chem. Biol. Drug Des., 2008, 72, 58-64.
57. Skerlavaj, B.; Gennaro, R.; Bagella, L.; Merluzzi, L.; Risso, A.; Zanetti, M. Biological characterisation of two novel cathelicidinderived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. J. Biol. Chem., 1996, 271, 28375-28381.
58. Orivel, J.; Redeker, V.; Le Caer, J.P.; Krier, F.; Revol-Junelles, A.M.; Longeon, A.; Chaffotte, A.; Dejean, A.; Rossier, J. Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii. J. Biol. Chem., 2001, 276, 17823-17829.
59. Conlon, J.M.; Sonnevend, A.; Davidson, C.; Smith, D.D.; Nielsen, P.F. The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei. Biochem. Biophys. Res. Commun., 2004, 320, 170-175.
60. Lee, D.G.; Kim, H.N.; Park, Y.; Kim, H.K.; Choi, B.H.; Choi, C-H.; Hahm, K-S. Design of novel analogue peptides with potent antibiotic activity based on the antimicrobial peptide, HP(2-20), derived from the N-terminus of Helicobacter pylori ribosomal protein L1. Biochim. Biophys. Acta, 2002, 1598, 185-194.
61. Tomasinsig, L.; Zanetti, M. The cathelicidins - structure, function and evolution. Curr. Prot. Pept. Sci., 2005, 6, 23-34.
62. Murakami, M.; Lopez-Garcia, B.; Braff, M.; Dorschner, R.A.; Gallo, R.L. Postsecretory processing generates multiple Cathelicidins for enhanced topical antimicrobial defense. J. Immunol., 2004, 172, 3070-3077.
63. López-García, B.; Ubhayasekera, W.; Gallo, R.; Marcos, J. Parallel evaluation of antimicrobial peptides derived from the synthetic PAF26 and the human LL37. Biochim. Biophys. Res. Comm., 2007, 356, 107-113.
64. Li, Y.; Li, X.; Wang, G. On-resin cleavage of bacterially expressed fusion proteins for purification of active recombinant peptides SK- 29, KR-20, LL-29, and LL-23 from human sweat or skin. Prot. Expr. Purif., 2007, 55, 395-405.
65. Kozlov, S.A.; Vassilevski, A.A.; Feofanov, A.V.; Surovoy, A.Y.; Karpunin, D.V.; Grishin, E.V. Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity. J. Biol. Chem., 2006, 281, 20983-20992.
66. Park, C.B.; Lee, J.H.; Park, I.Y.; Kim, M.S.; Kim, S.C. A novel antimicrobial peptide from the loach, Misgurnus anguillicaudatus. FEBS Lett., 1997, 411, 173-178.
67. Cho, J.H.; Sung, B.H.; Kim, S.C. Buforins: histone H2A-derived antimicrobial peptides from toad stomach. Biochim. Biophys. Acta, 2009, 1788, 1564-1569.
68. Kim, H.S.; Park, C.B.; Kim, M.S.; Kim, S.C. cDNA cloning and characterization of buforin I, an antimicrobial peptide: a cleavage product of histone H2A. Biochem. Biophys. Res. Commun., 1996, 229, 381-387.
69. Park, C.B.; Yi, K.S.; Matsuzaki, K.; Kim, M.S.; Kim, S.C. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: The proline hinge is responsible for the cellpenetrating ability of buforin II. Prot. Natl. Am. Sci., 2000, 97, 8245-8250.
70. Yi, G.S.; Park, C.B.; Kim, S.C.; Cheong, C. Solution structure of an antimicrobial peptide buforin II. FEBS Lett., 1996, 398, 87-90.
71. Park, C.B.; Kim, H.S.; Kim, S.C. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun., 1998, 244, 253-257.
72. Kobayashi, S.; Takeshima, K.; Park, C.B.; Kim, S.C.; Matsuzaki, K. Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor. Biochemistry, 2000, 39, 8648-8654.
73. Takeshima, K.; Chikushi, A.; Lee, K.K.; Yonehara, S.; Matsuzaki, K. Translocation of analogues of the antimicrobial peptides Magainin and Buforin across human cell membranes. J. Biol. Chem., 2003, 278, 1310-1315.
74. Sung, W.S.; Lee, J.; Lee, D.G. Fungicidal effect of piscidin on Candida albicans: pore formation in lipid vesicles and activity in fungal membranes. Biol. Pharm. Bull., 2008, 31, 1906-1910.
75. Cole, A.M.; Weis, P.; Diamond, G. Isolation and characterization of pleurocidin, an antimicrobial peptide in the skin secretions of winter flounder. J. Biol. Chem., 1997, 272, 12008-12013.
76. Sung, W.S.; Lee, D.G. Pleurocidin-derived antifungal peptides with selective membrane-disruption effect. Biochem. Biophys. Res. Commun., 2008, 369, 858-861.
77. Jung, H.J.; Park, Y.; sung, W.S.; Suh, B.K.; Lee, J.; Hahm, K-S.; Lee, D.G. Fungicidal effect of pleuricidin by membrane-active mechanism and design of enantiomeric analogue for proteolytic resistance. Biochim. Biophys. Acta, 2007, 1768, 1400-1405.
78. Fedders, H.; Leippe, M. A reverse search for antimicrobial peptides in Ciona intestinalis: identification of a gene family expressed in hemocytes and evaluation of activity. Dev. Comp. Immunol., 2008, 32, 286-298.
79. Vouldoukis, I.; Shai, Y.; Nicolas, P.; Mor, A. Broad spectrum antibiotic activity of skin-PYY. FEBS Lett., 1996, 380, 237-240.
80. Zasloff, M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Am. Sci., 1987, 84, 5449-5453.
81. Giacometti, A.; Cirioni, O.; Barchiesi, F.; Caselli, F.; Scalise, G. In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates. J. Antimicrob. Chemother., 1999, 44, 403-406.
82. Maloy, W.L.; Kari, U.P. Structure-activity studies on magainins and other host defense peptides. Biopolymers, 1995, 37, 105-122.
83. Jenssen, H.; Hamill, P.; Hancock, R.E. Peptide antimicrobial agents. Clin. Microbiol. Rev., 2006, 19, 491-511.
84. Haney, E.F.; Hunter, H.N.; Matsuzaki, K.; Vogel, H.J. Solution NMR studies of amphibian antimicrobial peptides: linking structure to function? Biochim. Biophys. Acta, 2009, 1788, 1639-1655.
85. Moore, K.S.; Bevins, C.L.; Brasseur, M.M.; Tomassini, N.; Turner, K.; Eck, H.; Zasloff, M. Antimicrobial peptides in the stomach of Xenopus laevis. J. Biol. Chem., 1991, 266, 19851-19857.
86. Soravia, E.; Martini, G.; Zasloff, M. Antimicrobial properties of peptides from Xenopus granular gland secretions. FEBS Lett., 1988, 228, 337-340.
87. Ramamoorthy, A.; Thennarasu, S.; Lee, D.K.; Tan, A.; Maloy, L. Solid-state NMR investigation of the membrane-disrupting mechanism of antimicrobial peptides MSI-78 and MSI-594 derived from magainin 2 and melittin. Biophys. J., 2006, 91, 206-216.
88. Gottler, L.M.; Ramamoorthy, A. Structure, membrane orientation, mechanism, and function of pexiganan - a highly potent antimicrobial peptide designed from magainin. Biochim. Biophys. Acta., 2009, 1788, 1680-1686.
89. Porcelli, F.; Buck-Koehntop, B.A.; Thennarasu, S.; Ramamoorthy, A.; Veglia, G. Structures of the dimeric and monomeric variants of magainin antimicrobial peptides (MSI-78 and MSI-594) in micelles and bilayers, determined by NMR spectroscopy. Biochemistry, 2006, 45, 5793-5799.
90. Leem, Y.; Park, D.S.; Suh, E.Y.; Hur, J.H.; Oh, H.W.; Park, H.Y. Isolation and functional analysis of a 24-residue linear alpha-helical antimicrobial peptide from Korean blackish cicada, Cryptotympana dubia (Homoptera). Arch. Insect Biochem. Physiol., 2007, 66, 204-213.
91. Lamberty, M.; Zachary, D.; Lanot, R.; Bordereau, C.; Robert, A.; Hoffmann, J.A.; Bulet, P. Insect immunity. Constitutive expression of a cysteine-rich antifungal and a linear antibacterial peptide in a termite insect. J. Biol. Chem., 2001, 276, 4085-4092.
92. Lee, K.H.; Shin, S.Y.; Hong, J.E.; Yang, S.T.; Kim, J.I.; Hahm, K.S.; Kim, Y. Solution structure of termite-derived antimicrobial peptide, spinigerin, as determined in SDS micelle by NMR spectroscopy. Biochem. Biophys. Res. Commun., 2003, 309, 591-597.
93. Landon, C.; Meudal, H.; Boulanger, N.; Bulet, P.; Vovelle, F. Solution structures of stomoxyn and spinigerin, two insect antimicrobial peptides with an alpha-helical conformation. Biopolymers, 2006, 81, 92-103.
94. Bobek, L.A.; Situ, H. MUC7 20-Mer: investigation of antimicrobial activity, secondary structure, and possible mechanism of antifungal action. Antimicrob. Agents Chemother., 2003, 47, 643-652.
95. Situ, H.; Bobek, L.A. In vitro assessment of antifungal therapeutic potential of salivary Histatin-5, two variants of Histatin-5, and a salivary Mucin (MUC7) domain 1. Antimicrob. Agents Chemother., 2000, 44, 1485-1493.
96. Situ, H.; Wei, G.; Smith, C.J.; Mashhoon, S.; Bobek, L.A. Human salivary MUC7 mucin peptides: effect of size, charge and cysteine residues on antifungal activity. Biochem. J., 2003, 375, 175-182.
97. Wei, G-X.; Bobek, L. Human salivary mucin MUC7 12-mer-L and 12-mer-D peptides: antifungal activity in saliva, enhancement of activity with protease inhibitor cocktail or EDTA, and cytotoxicity to human cells. Antimicrob. Agents Chemother., 2005, 49, 2336-2342.
98. Desbois, A.P.; Coote, P.J. Bactericidal synergy of lysostaphin in combination with antimicrobial peptides. Eur. J. Clin. Microbiol. Infect. Dis., 2011, DOI: 10.1007/s10096-011-1188-z.
99. Clark, D.P.; Durell, S.; Maloy, W.L.; Zasloff, M. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin. J. Biol. Chem., 1994, 269, 10849-10855.
100. Desbois, A.P.; Gemmell, C.G.; Coote, P.J. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections. Int. J. Antimicrob. Agents, 2010, 35, 559-565.
101. Li, J.; Xu, X.; Xu, C.; Zhou, W.; Zhang, K.; Yu, H.; Zhang, Y.; Zheng, Y.; Rees, H.H.; Lai, R.; Yang, D.; Wu, J. Anti-infection peptidomics of amphibian skin. Mol. Cell. Proteomics, 2007, 6, 882-894.
102. Park, S.; Park, S.H.; Ahn, H.C.; Kim, S.; Kim, S.S.; Lee, B.J.; Lee, B.J. Structural study of novel antimicrobial peptides, nigrocins, isolated from Rana nigromaculata. FEBS Lett., 2001, 507, 95-100.
103. Conlon, J.M.; Sonnevend, A.; Patel, M.; Davidson, C.; Nielsen, P.F.; Pal, T.; Rollins-Smith, L.A. Isolation of peptides of the brevinin- 1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii. J. Pept. Res., 2003, 62, 207-213.
104. Goraya, J.; Wang, Y.; Li, Z.; O'Flaherty, M.; Knoop, F.C.; Platz, J.E.; Conlon, J.M. Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens. Eur. J. Biochem., 2000, 267, 894-900.
105. Lee, K.H.; Hong, S.Y.; Oh, J.E.; Lee, B.J.; Choi, B.S. Antimicrobial activity and conformation of gaegurin-6 amide and its analogs. Peptides, 1998, 19, 1653-1658.
106. Park, J.M.; Jung, J.E.; Lee, B.J. Antimicrobial peptides from the skin of a Korean frog, Rana rugosa. Biochem. Biophys. Res. Commun., 1994, 205, 948-954.
107. Park, S.H.; Kim, H.E.; Kim, C.M.; Yun, H.J.; Choi, E.C.; Lee, B.J. Role of proline, cysteine and a disulphide bridge in the structure and activity of the anti-microbial peptide gaegurin 5. Biochem. J., 2002, 368, 171-182.
108. Suh, J.Y.; Lee, Y.T.; Park, C.B.; Lee, K.H.; Kim, S.C.; Choi, B.S. Structural and functional implications of a proline residue in the antimicrobial peptide gaegurin. Eur. J. Biochem., 1999, 266, 665-674.
109. Sai, K.P.; Jagannadham, M.V.; Vairamani, V.; Raju, N.P.; Devi, A.S.; Nagaraj, R.; Sitaram, N. Tigerinins: novel antimicrobial peptides from the Indian frog Rana tigerina. J. Biol. Chem., 2001, 276, 2701-2707.
110. Cutuli, M.; Cristiani, S.; Lipton, J.M.; Catania, A. Antimicrobial effects of alpha-MSH peptides. J. Leuko. Biol., 2000, 67, 233-239.
111. Catania, A.; Grieco, P.; Randazzo, A.; Novellino, E.; Gatti, S.; Rossi, C.; Colombo, G.; Lipton, J.M. Three-dimensional structure of the alpha-MSH-derived candidacidal peptide [Ac-CKPV]2. J. Pept. Res., 2005, 66, 19-26.
112. Carotenuto, A.; Saviello, M.R.; Auriemma, L.; Campiglia, P.; Catania, A.; Novellino, E.; Grieco, P. Structure-function relationships and conformational properties of alpha-MSH(6-13) analogues with candidacidal activity. Chem. Biol. Drug Des., 2007, 69, 68-74.
113. Rauch, I.; Holzmeister, S.; Kofler, B. Anti-Candida activity of α- melanocyte-stimulating hormone (α-MSH) peptides. J. Leuko. Biol., 2009, 85, 371-372.
114. Kokryakov, V.N.; Harwig, S.S.; Panyutich, E.A.; Shevchenko, A.A.; Aleshina, G.M.; Shamova, O.V.; Korneva, H.A.; Lehrer, R.I. Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett., 1993, 327, 231-236.
115. Fahrner, R.L.; Dieckmann, T.; Harwig, S.S.; Lehrer, R.I.; Eisenberg, D.; Feigon, J. Solution structure of protegrin-1, a broadspectrum antimicrobial peptide from porcine leukocytes. Chem. Biol., 1996, 3, 543-550.
116. Harwig, S.S.; Swiderek, K.M.; Lee, T.D.; Lehrer, R.I. Determination of disulphide bridges in PG-2, an antimicrobial peptide from porcine leukocytes. J. Pept. Sci., 1995, 1, 207-215.
117. Cho, Y.; Turner, J.S.; Dinh, N.N.; Lehrer, R.I. Activity of Protegrins against yeast-phase Candida albicans. Infect. Immun., 1998, 66, 2486-2493.
118. Benincasa, M.; Scocchi, M.; Pacor, S.; Tossi, A.; Nobili, D.; Basaglia, G.; Busetti, M.; Gennaro, R. Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. J. Antimicrob. Chemother., 2006, 58, 950-959.
119. Aumelas, A.; Mangoni, M.; Roumestand, C.; Chiche, L.; Despaux, E.; Grassy, G.; Calas, B.; Chavanieu, A. Synthesis and solution structure of the antimicrobial peptide protegrin-1. Eur.J. Biochem., 1996, 237, 575-583.
120. Silva, P.I., Jr.; Daffre, S.; Bulet, P. Isolation and characterization of Gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the Tachyplesin family. J. Biol. Chem., 2000, 275, 33464-33470.
121. Tran, D.; Tran, P.; Roberts, K.; Osapay, G.; Schaal, J.; Ouellette, A.; Selsted, M.E. Microbicidal properties and cytocidal selectivity of Rhesus macaque theta defensins. Antimicrob. Agents Chemother., 2008, 52, 944-953.
122. Steinstraesser, L.; Tack, B.F.; Waring, A.J.; Hong, T.; Boo, L.M.; Fan, M.H.; Remick, D.I.; Su, G.L.; Lehrer, R.I.; Wang, S.C. Activity of Novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns. Antimicrob. Agents Chemother., 2002, 46(6), 1837-1844.
123. Barchiesi, F.; Giacometti, A.; Cirioni, O.; Arzeni, D.; Kamysz, W.; Silvestri, C.; Licci, A.; Marigliano, A.; Della Vottoria, A.; Nadolski, P.; Lukasiak, J.; Scalise, G. In vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp. J. Chemother., 2007, 19, 514-518.
124. Toney, J.H. Iseganan (IntraBiotics pharmaceuticals). Curr. Opin. Investig. Drugs, 2002, 3, 225-228.
125. Kollef M,; Pittet, D.; Sánchez Garcìa, M.; Chastre, J.; Fagon, J-Y.; Bonten, M.; Hyzy, R.; Fleming, T.R.; Fuchs, H.; Bellm, L.; Mercat, A.; Mañez, R.; Martínez, A.; Eggimann, P.; Daguerre, M.; Luyt, CE. A randomised double-blind trial of iseganan in prevention of ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med., 2006, 173, 91-97.
126. Mangoni, M.L.; Papo, N.; Mignogna, G.; Andreu, D.; Shai, Y.; Barra, D.; Simmaco, M. Ranacyclins, a new family of short cyclic antimicrobial peptides: biological function, mode of action, and parameters involved in target specificity. Biochemistry, 2003, 42, 14023-14035.
127. Miyata, T.; Tokunaga, F.; Yoneya, T.; Yoshikawa, K.; Iwanaga, S.; Niwa, M.; Takao, T.; Shimonishi, Y. Antimicrobial peptides, isolated from Horseshoe crab hemocytes, Tachyplesin II, and Polyphemusins I and II: chemical structures and biological activity. J. Biochem., 1989, 106, 663-668.
128. Kawano, K.; Yoneya, T.; Miyata, T.; Yoshikawa, K.; Tokunaga, F.; Terada, Y.; Iwanaga, S. Antimicrobial peptide, tachyplesin I, isolated from hemocytes of the horseshoe crab (Tachypleus tridentatus): NMR determination of the beta- sheet structure. J. Biol. Chem., 1990, 265, 15365-15367.
129. Nakamura, T.; Furunaka, H.; Miyata, T.; Tokunaga, F.; Muta, T.; Iwanaga, S.; Niwa, M.; Takao, T.; Shimonishi, Y. Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure. J. Biol. Chem., 1988, 263, 16709-16713.
130. Rao, A.G. Conformation and antimicrobial activity of linear derivatives of tachyplesin lacking disulfide bonds. Arch. Biochem. Biophys., 1999, 361, 127-134.
131. Powers, J.P.; Rozek, A.; Hancock, R.E. Structure-activity relationships for the beta-hairpin cationic antimicrobial peptide polyphemusin I. Biochim. Biophys. Acta, 2004, 1698, 239-250.
132. Zhang, L.; Scott, M.G.; Yan, H.; Mayer, L.D.; Hancock, R.E. Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers. Biochemistry, 2000, 39, 14504-14514.
133. Tam, J.P.; Lu, Y.A.; Yang, J.L. Correlations of cationic charges with salt sensitivity and microbial specificity of cystine-stabilized β-strand antimicrobial peptides. J. Biol. Chem., 2002, 277, 50450-50456.
134. Katsu, T.; Nakao, S.; Iwanaga, S. Mode of action of an antimicrobial peptide, tachyplesin I, on biomembranes. Biol. Pharm. Bull., 1993, 16, 178-181.
135. Moraes, L.G.M.; Fazio, M.; Vieira, R.F.F.; Nakaie, C.R.; Miranda, M.T.M.; Schreier, S.; Daffre, S.; Miranda, A. Conformational and functional studies of gomesin analogues by CD, EPR and fluorescence spectroscopies. Biochim. Biophys. Acta, 2007, 1768, 52-58.
136. Ganz, T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood, 2003, 102, 783-788.
137. Hunter, H.N.; Fulton, D.B.; Ganz, T.; Vogel, H.J. The solution structure of human Hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary Hemochromatosis. J. Biol. Chem., 2002, 277, 37597-37603.
138. Park, C.H.; Valore, E.V.; Waring, A.J.; Ganz, T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem., 2001, 276, 7806-7810.
139. Krause, A.; Neitz, S.; Magert, H.J.; Schulz, A.; Forssmann, W.G.; Schulz-Knappe, P.; Adermann, K. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett., 2000, 480, 147-150.
140. Tailor, R.H.; Acland, D.P.; Attenborough, S.; Cammue, B.P.; Evans, I.J.; Osborn, R.W.; Ray, J.A.; Rees, S.B.; Broekaert, W.F. A novel family of small cysteine-rich antimicrobial peptides from seed of Impatiens balsamina is derived from a single precursor protein. J. Biol. Chem., 1997, 272, 24480-24487.
141. Thevissen, K.; Francois, I.E.; Sijtsma, L.; Van Amerongen, A.; Schaaper, W.M.; Meloen, R.; Postuma-Trumpie, T.; Broekaert, W.F.; Cammue, B.P. Antifungal activity of synthetic peptides derived from Impatiens balsamina antimicrobial peptides Ib-AMP1 and Ib-AMP4. Peptides, 2005, 26, 1113-1119.
142. Patel, S.U.; Osborn, R.; Rees, S.; Thornton, J.M. Structural studies of Impatiens balsamina antimicrobial protein (Ib-AMP1). Biochemistry, 1998, 37, 983-990.
143. Arias, H.R.; Blanton, M.P. Alpha-conotoxins. Int. J. Biochem.Cell Biol., 2000, 32, 1017-1028.
144. Ovchinikova, T.V.; Aleshina, G.M.; Balandin, S.V.; Krasnosdembskaya, A.D.; Markelov, M.L.; Frolova, E.I.; Leonova, Y.F.; Tagaev, A.A.; Krasnodembsky, E.G.; Kokryakov, V.N. Purification and primary structure of two isoforms of arenicin, a novel antimicrobial peptide from marine polychaeta Arenicola marina. FEBS Lett., 2004, 577, 209-214.
145. Lee, J.U.; Kang, D.I.; Zhu, W.L.; Shin, S.Y.; Hahm, K.S.; Kim, Y. Solution structures and biological functions of the antimicrobial peptide, arenicin-1, and its linear derivative. Biopolymers, 2007, 88, 208-216.
146. Park, C; Lee, D.G. Fungicidal effect of antimicrobial peptide arencin-1. Biochim. Biophys. Acta, 2009, 1788, 1790-1796.
147. Ehret-Sabatier, L.; Loew, D.; Goyffon, M.; Fehlbaum, P.; Hoffmann, J.A.; Van Dorsselaer, A.; Bulet, P. Characterization of novel cysteine-rich antimicrobial peptides from Scorpion blood. J. Biol. Chem., 1996, 271, 29537-29544.
148. Mandard, N.; Sy, D.; Maufrais, C.; Bonmatin, J.M.; Bulet, P.; Hetru, C.; Vovelle, F. Androctonin, a novel antimicrobial peptide from scorpion Androctonus australis: solution structure and molecular dynamics simulations in the presence of a lipid monolayer. J. Biomol. Struct. Dyn., 1999, 17, 367-380.
149. Blondelle, S.E.; Houghten, R.A. Novel antimicrobial compounds identified using synthetic combinatorial library technology. Trends Biotechnol., 1996, 14, 60-65.
150. Blondelle, S.E.; Takahashi, E.; Dinh, K.T.; Houghten, R.A. The antimicrobial activity of hexapeptides derived from synthetic combinatorial libraries. J. Appl. Bact. 1995, 78, 39-46.
151. Dathe, M.; Nikolenko, H.; Klose, J.; Bienert, M. Cyclization increases the antimicrobial activity and selectivity of arginine- and tryptophan-containing hexapeptides. Biochemistry, 2004, 43, 9140-9150.
152. Da Silva, A.; Kawazoe, U.; Freitas, F.F.; Gatti, M.S.; Dolder, H.; Schumacher, R.I., Juliano, M.A.; Da Silva, M.J.; Leite, A. Avian anticoccidial activity of a novel membrane-interactive peptide selected from phage display libraries. Mol. Biochem. Parasitol., 2002, 120, 53-60.
153. Tinoco, L.W.; Da Silva, A., Jr; Leite, A.; Valente, A.P.; Almeida, F.C. NMR Structure of PW2 bound to SDS micelles. A tryptophanrich anticoccidial peptide selected from pahge display libraries. J. Biol. Chem., 2002, 277, 36351-36356.
154. Selsted, M.E.; Novotny, M.J.; Morris, W.L.; Tang, Y.Q.; Smith, W.; Cullor, J.S. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J. Biol. Chem., 1992, 267, 4292-4295.
155. Yang, S.T.; Yub Shin, S.Y.; Kim, Y.C.; Kim, Y.; Hahm, K.S.; Kim, J.I. Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide. Biochem. Biophys. Res. Commun., 2002, 296, 1044-1050.
156. Lee, D.G.; Kim, H.K.; Kim, S.A.; Park, Y.; Park, S.C.; Jang, S.H.; Hahm, K.S. Fungicidal effect of indolicidin and its interaction with phospholipid membranes. Biochem. Biophys. Res. Commun., 2003, 305, 305-310.
157. Fritsche, T.R.; Rhomberg, P.R.; Sader, H.S.; Jones, R.N. Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheterassociated infections. J. Antimicrob. Chemother., 2008, 61, 1092-1098.
158. Melo, M.N.; Dugourd, D.; Castanho, M.A. Omiganan pentahydrochloride in the front line of clinical applications of antimicrobial peptides. Recent Pat. Antinf. Drug Disc., 2006, 1, 201-207.
159. Schibli, D.J.; Hwang, P.M.; Vogel, H.J. Structure of the antimicrobial peptide tritrpticin bound to micelles: a distinct membranebound peptide fold. Biochemistry, 1999, 38, 16749-16755.
160. Lawyer, C.; Pai, S.; Watabe, M.; Borgia, P.; Mashimo, T.; Eagleton, L.; Watabe, K. Antimicrobial activity of a 13 amino acid tryptophan- rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides. FEBS Lett., 1996, 390, 95-98.
161. Briolat, J.; Wu, S.D.; Mahata, S.K.; Gonthier, B.; Bagnard, D.; Chasserot-Golaz, S.; Helle, K.B.; Aunis, D.; Metz-Boutigue, M.H. New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A. Cell. Mol. Life Sci., 2005, 62, 377-385.
162. Jean-Francois, F.; Khemtemourian, L.; Odaert, B.; Castano, S.; Grelard, A.; Manigand, C.; Bathany, K.; Metz-Boutigue, M.H.; Dufourc, E.J. Variability in secondary structure of the antimicrobial peptide Cateslytin in powder, solution, DPC micelles and at the airwater interface. Eur. Biophys. J., 2007, 36, 1019-1027.
163. Jean-Francois, F.; Castano, S.; Desbat, B.; Odaert, B.; Roux, M.; Metz-Boutigue, M.H.; Dufourc, E.J. Aggregation of cateslytin beta-sheets on negatively charged lipids promotes rigid membrane domains. A new mode of action for antimicrobial peptides? Biochemistry, 2008, 47, 6394-6402.
164. Jean-Francois, F.; Elezgaray, J.; Berson, P.; Vacher, P.; Dufourc, E.J. Pore formation induced by an antimicrobial peptide: electrostatic effects. Biophys. J., 2008, 95, 5748-5756.
165. Oppenheim, F.G.; Xu, T.; McMillian, F.M.; Levitz, S.M.; Diamond, R.D.; Offner, G.D.; Troxler, R.F. Histatins, a novel family of histidine-rich proteins in human parotid secretion: Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J. Biol. Chem., 1988, 263, 7472-7477.
166. Troxler, R.F.; Offner, G.D.; Xu, T.; Vanderspek, J.C.; Oppenheim, F.G. Structural relationship between human salivary Histatins. J. Dental Res., 1990, 69, 2-6.
167. Rothstein, D.M.; Spacciapoli, P.; Tran, L.T.; Xu, T.; Roberts, F.D.; Dalla Serra, M.; Buxton, D.K.; Oppenheim, F.G.; Friden, P. Anticandida activity is retained in P-113, a 12-amino-acid fragment of Histatin 5. Antimicrob. Agents Chemother., 2001, 45, 1367-1373.
168. Nikawa, H.; Fukushima, H.; Makihira, S.; Hamada, T.; Samaranayake, L.P. Fungicidal effect of three new synthetic cationic peptides against Candida albicans. Oral Dis., 2004, 10, 221-228.
169. Ruissen, A.L.; Groenink, J.; Van't Hof, W.; Walgreen-Weterings, E.; Van Marle, J.; Van Veen, H.A.; Voorhout, W.F.; Veerman, E.C.; Nieuw Amerongen, A.V. Histatin 5 and derivatives: Their localization and effects on the ultra-structural level. Peptides, 2002, 23, 1391-1399.
170. Helmerhorst, E.J.; Van't Hof, W.; Breeuwer, P.; Veerman, E.C.; Abee, T.; Troxler, R.F.; Amerongen, A.V.; Oppenheim, F.G. Characterization of Histatin 5 with respect to amphipathicity, hydrophobicity, and effects on cell and mitochondrial membrane integrity excludes a Candidacidal mechanism of pore formation. J. Biol. Chem., 2001, 276, 643-5649.
171. Helmerhorst, E.J.; Venuleo, C.; Beri, A.; Oppenheim, F.G. Candida glabrata is unusual with respect to its resistance to cationic antifungal proteins. Yeast, 2005, 22, 705-714.
172. Raj, P.A.; Marcus, E.; Sukumaran, D.K. Structure of human salivary histatin 5 in aqueous and nonaqueous solutions. Biopolymers, 1998, 45, 51-67.
173. Den Hertog, A.L.; Van Marle, J.; Van Veen, H.A.; Van't Hof, W.; Bolscher, J.G.; Veerman, E.C.; Nieuw Amerongen, A.V. Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochem. J., 2005, 388, 689-695.
174. Mochon, A.B.; Liu, H. The antimicrobial peptide histatin-5 causes a spatially restricted disruption on the Candida albicans surface, allowing rapid entry of the peptide into the cytoplasm. PLoS Path., 2008, 4, e1000190.
175. De Smet, K.; Contreras, R. Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol. Lett., 2005, 27, 1337-1347.
176. Edgerton, M.; Koshlukova, S.E. Salivary Histatin 5 and its similarities to the other antimicrobial proteins in human saliva. Adv. Dental Res., 2000, 14, 16-21.
177. Koshlukova, S.E.; Araujo, M.W.; Baev, D.; Edgerton, M. Released ATP is an extracellular cytotoxic mediator in salivary Histatin 5- induced killing of Candida albicans. Infect. Immun., 2000, 68, 6848-6856.
178. Li, X.S.; Reddy, M.S.; Baev, D.; Edgerton, M. Candida albicans Ssa1/2p is the cell envelope binding protein for human salivary Histatin 5. J. Biol. Chem., 2003, 278, 28553-28561.
179. Sun, J.N.; Li, W.; Jang, W.S.; Nayyar, N.; Sutton, M.D.; Edgerton, M. Uptake of the antifungal cationic peptide Histatin 5 by Candida albicans Ssa2p requires binding to non-conventional sites within the ATPase domain. Mol. Microbiol., 2008, 70, 1246-1260.
180. Mickels, N.; McManus, C.; Massaro, J.; Friden, P.; Braman, V.; D'Agostino, R.; Oppenheim, F.; Warbington, M.; Dibart, S.; Van Dyke, T. Clinical and microbial evaluation of a histatin-containing mouthrinse in humans with experimental gingivitis. J. Clin. Periodontol., 2001, 28, 404-410.
181. Paquette, D.W.; Simpson, D.M.; Friden, P.; Braman, V.; Williams, R.C. Safety and clinical effects of topical histatin gels in humans with experimental gingivitis. J. Clin. Periodontol., 2002, 29, 1051-1058.
182. Groot, F.; Sanders, R.W.; Ter Brake, O.; Nazmi, K.; Veerman, E.C.; Bolscher, J.G.; Berkhout, B. Histatin 5-derived peptide with improved fungicidal properties enhances Human Immunodeficiency Virus Type 1 replication by promoting viral entry. J. Virol., 2006, 80, 9236-9243.
183. Lupetti, A.; van Dissel, J.T.; Brouwer, J.M.; Nibbering, P.H. Human antimicrobial peptides' antifungal activity against Aspergillus fumigatus. Eur. J. Clin. Microbiol. Infect. Dis., 2008, 27, 1125-1129.
184. Lai, R.; Liu, H.; Lee, W.H.; Zhang, Y. A novel proline rich bombesin-related peptide (PR-bombesin) from toad Bombina maxima. Peptides, 2002, 23, 437-442.
185. Li, J.; Xu, X.; Yu, H.; Yang, H.; Huang, Z.; Lai, R. Direct antimicrobial activities of PR-bombesin. Life Sci., 2006, 78, 1953-1956.
186. Cabras, T.; Longhi, R.; Secundo, F.; Nocca, G.; Conti, S.; Polonelli, L.; Fanali, C.; Inzitari, R.; Petruzzelli, R.; Messana, I.; Castagnola, M.; Vitali, A. Structural and functional characterization of the porcine proline-rich antifungal peptide SP-B isolated from salivary gland granules. J. Pept. Sci., 2008, 14, 251-260.
187. Jenssen, H.; Hamill, P.; Hancock, R.E.W. Peptide antimicrobial agents. Clin. Microbiol. Rev., 2006, 19, 491-511.
188. Vogel, H.J.; Schibli, D.J.; Jing, W.; Lohmeier-Vogel, E.M.; Epand, R.F.; Epand, R.M. Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides. Biochem. Cell Biol., 2002, 80, 49-63.
189. Gifford, J.L.; Hunter, H.N.; Vogel, H.J. Lactoferricin: a lactoferrinderived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell. Mol. Life Sci., 2005, 62, 2588-2598.
190. Bellamy, W.; Yamauchi, K.; Wakabayashi, H.; Takase, M.; Takakura, N.; Shimamura, S.; Tomita, M. Antifungal properties of lactoferricin B, a peptide derived from the N-terminal region of bovine lactoferrin. Lett. Appl. Microbiol., 1994, 18, 230-233.
191. Wakabayashi, H.; Matsumoto, H.; Hashimoto, K.; Teraguchi, S.; Takase, M.; Hayasawa, H. N-acylated and D-enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity. Antimicrob. Agents Chemother., 1999, 43, 1267-1269.
192. Bellamy, W.; Takase, M.; Yamauchi, K.; Wakabayashi, H.; Kawase, K.; Tomita, M. Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta, 1992, 1121, 130-136.
193. Ueta, E.; Tanida, T.; Osaki, T. A novel bovine lactoferrin peptide, FKCRRWQWRM, suppresses Candida cell growth and activates neutrophils. J. Pept. Res., 2001, 57, 240-249.
194. Hwang, P.M.; Zhou, N.; Shan, X.; Arrowsmith, C.H.; Vogel, H.J. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. Biochemistry, 1998, 37, 4288-4298.
195. Kanyshkova, T.G.; Semenov, D.V.; Buneva, V.N.; Nevinsky, G.A. Human milk lactoferrin binds two DNA molecules with different affinities. FEBS Lett., 1999, 451, 235-237.
196. Okamoto, T.; Tanida, T.; Wei, B.; Ueta, E.; Yamamoto, T.; Osaki, T. Regulation of fungal infection by a combination of amphotericin B and peptide 2, a lactoferrin peptide that activates neutrophils. Clin. Diagn. Lab. Immun., 2004, 11, 1111-1119.
197. Tanida, T.; Okamoto, T.; Ueta, E.; Yamamoto, T.; Osaki, T. Antimicrobial peptides enhance the candidacidal activity of antifungal drugs by promoting the efflux of ATP from Candida cells. J. Antimicrob. Chemother., 2006, 57, 94-103.
198. Lupetti, A.; Paulusma-Annema, A.; Welling, M.M.; Senesi, S.; Van Dissel, J.T.; Nibbering, P.H. Candidacidal activities of human lactoferrin peptides derived from the N terminus. Antimicrob. Agents Chemother., 2000, 44, 3257-3263.
199. Lupetti, A.; Brouwer, C.P.J.M.; Dogterom-Ballering, H.E.C.; Senesi, S.; Campa, M.; Van Dissel, J.T.; Nibbering, P.H. Release of calcium from intracellular stores and subsequent uptake by mitochondria are essential for the candidacidal activity of an N-terminal peptide of human lactoferrin. J. Antimicrob. Chemother., 2004, 54, 603-608.
200. Lupetti, A.; Paulusma-Annema, A.; Welling, M.M.; Dogterom- Ballering, H.; Brouwer, C.P.J.M.; Senesi, S.; Van Dissel, J.T.; Nibbering, P.H. Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species. Antimicrob. Agents Chemother., 2003, 47, 262-267.
201. Leonova, L.; Kokryakov, V.N.; Aleshina, G.; Hong, T.; Nguyen, T.; Zhao, C.; Waring, A.J.; Lehrer, R.I. Circular minidefensins and posttranslational generation of molecular diversity. J. Leuko. Biol., 2001, 70, 461-464.
202. Tang, Y.Q.; Yuan, J.; Osapay, G.; Osapay, K.; Tran, D.; Miller, C.J.; Ouellette, A.J; Selsted, M.E. Cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated α- defensins. Science, 1999, 286, 498-502.
203. Trabi, M.; Schirra, H.J.; Craik, D.J. Three-dimensional structure of RTD-1, a cyclic antimicrobial defensin from Rhesus macaque leukocytes. Biochemistry, 2001, 40, 4211-4221.
204. Fehlbaum, P.; Bulet, P.; Chernysh, S.; Briand, J.P.; Roussel, J.P.; Letellier, L.; Hetru, C.; Hoffmann, J.A. Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides. Proc. Natl. Am. Sci., 1996, 93, 1221-1225.
205. Mandard, N.; Sodano, P.; Labbe, H.; Bonmatin, J.M.; Bulet, P.; Hetru, C.; Ptak, M.; Vovelle, F. Solution structure of thanatin, a potent bactericidal and fungicidal insect peptide, determined from proton two-dimensional nuclear magnetic resonance data. Eur. J. Biochem., 1998, 256, 404-410.
206. Lopez-Garcia, B.; Perez-Paya, E.; Marcos, J.F. Identification of novel hexapeptides bioactive against phytopathogenic fungi through screening of a synthetic peptide combinatorial library. Appl. Environ. Microbiol., 2002, 68, 2453-2460.
207. Munoz, A.; Lopez-Garcia, B.; Marcos, J.F. Studies on the mode of action of the antifungal hexapeptide PAF26. Antimicrob. Agents Chemother., 2006, 50, 3847-3855.
208. López-García, B.; Marcos, J.; Abad, C.; Pérez-Payá, E. Stabilisation of mixed peptide/lipid complexes in selective antifungal hexapeptides. Biochim. Biophys. Acta, 2004, 1660, 131-137.
209. Pollonelli, L.; Magliani, W.; Conti, S.; Bracci, L.; Lozzi, L.; Neri, P.; Adriani, D.; De Bernardis, F.; Cassone, A. Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis. Infect. Immun., 2003, 71, 6205-6212.
210. Subramanian, S.; Ross, N.W.; MacKinnon, S.L. Myxinidin, a novel antimicrobial peptide from the epidermal mucus of hagfish, Myxine glutinosa L. Mar. Biotech., 2009, 11, 748-757.
211. Chen, L.; Li, Y.; Li, J.; Xu, X.; Lai, R.; Zou, Q. An antimicrobial peptide with antimicrobial activity against Helicobacter pylori. Peptides, 2007, 28, 1527-1531.
212. Park, I.Y.; Park, C.B.; Kim, M.S.; Kim, S.C. Parasin I, an antimicrobial peptide derived from histone H2A in the catfish, Parasilurus asotus. FEBS Lett., 1998, 437, 258-262.
213. Koo, Y.S.; Kim, J.M.; Park, I.Y.; Yu, B.J.; Jang, S.A.; Kim, K.S.; Park, C.B.; Cho, J.H.; Kim, S.C. Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide. Peptides, 2008, 29, 1102-1108.
214. Park, Y.; Choi, B.H.; Kwak, J-S.; Kang, C-W.; Lim, H-T.; Cheong, H-S.; Hahm, K-S. Kunitz-type serine protease from potato (Solanum tuberosum L. cv. Jopung). J. Agric. Food Chem., 2005, 53, 6491-6496.
215. Yu, D.; Sheng, Z.; Xu, X.; Li, J.; Yang, H.; Liu, Z.; Rees, H.H.; Lai, R. A novel antimicrobial peptide from salivary glands of the hard tick, Ixodes sinensis. Peptides, 2006, 27, 31-35.
216. Argiolas, A.; Pisano, J.J. Bombolitins, a new class of mast cell degranulating peptides from the venom of the bumblebee Megabombus pennsylvanicus. J. Biol. Chem., 1985, 260, 1437-1444.
217. Budnik, B.A.; Olsen, J.V.; Egorov, T.A.; Anisimova, V.E.; Galkina, T.G.; Musolyamov, A.K.; Grishin, E.V.; Zubarev, R.A. De novo sequencing of antimicrobial peptides isolated from the venom glands of the wolf spider Lycosa singoriensis. J. Mass Spectrom., 2004, 39, 193-201.
218. Destoumieux-Garzón, D.; Saulnier, D.; Garnier, J.; Jouffrey, C.; Bulet, P.; Bachère, E. Crustacean Immunity. Antifungal peptides are generated from the C terminus of shrimp hemocyanin in response to microbial challenge. J. Biol. Chem., 2001, 276, 47070-47077.
219. Wong, J.H.; Ng, T.B. Sesquin, a potent defensin-like antimicrobial peptide from ground beans with inhibitory activities toward tumor cells and HIV-1 reverse transcriptase. Peptides, 2005, 26, 1120-1126.
220. Chia, B.C.; Carver, J.A.; Mulhern, T.D.; Bowie, J.H. The solution structure of uperin 3.6, an antibiotic peptide from the granular dorsal glands of the Australian toadlet, Uperoleia mjobergii. J. Pept. Res.,1999, 54, 137-145.
221. Patrzykat, A.; Gallant, J.W.; Seo, J.K.; Pytyck, J.; Douglas, S.E. Novel antimicrobial peptides derived from flatfish genes. Antimicrob. Agents Chemother., 2003, 47, 2464-2470.
222. Schulze, J.A.; Nakamura, M. Haemolytic activity of the alpha and theta toxins of Clostridium welchii. J. Hyg., 1969, 67, 163-174.
223. Zou, C-G.; Agar, N.S.; Jones, G.L. Haemolysis of human and sheep red blood cells in glycerol media: effect of pH and the role of band 3. Comp. Biochem. Physiol. A, 2000, 127, 347-353.
224. Harris, M.R.; Coote, P.J. Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. Int. J. Antimicrob. Agents, 2010, 35, 347-356.
225. Mylonakis, E.; Moreno, R.; El Khoury, J.B.; Idnurm, A.; Heitman, J.; Calderwood, S.B.; Ausubel, F.M.; Diener, A. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect. Immun., 2005, 73, 3842-3850.
226. Kavanagh, K.; Reeves, E.P. Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens. FEMS Microbiol. Rev., 2004, 28, 101-112.